After experiencing a health crisis related to topical steroid use to treat eczema, Kelly was propelled into the world of advocacy. Her passion to raise awareness, find solutions and support those suffering as she had, led her to serve on several national and international dermatology non-profits, highlighting the great needs of the eczema and TSW communities in medical, academic, regulatory and health policy arenas. Kelly serves as Executive Director of the Coalition of Skin Diseases (CSD), a group of national non-profit skin-related patient groups, which advocates for the 84+ million people in the United States living with skin conditions. She also serves as President of the patient advocacy group, International Topical Steroid Awareness Network (ITSAN), which raises awareness to TSW and supports affected individuals. Other advocacy roles include representing the CSD on the Patient Advocacy and Drug Transparency Task Forces of the American Academy of Dermatology (AAD); the FDA & CTTI Patient Engagement Collaborative and serving on the Atopic Eczema Advisory Panel for Globalskin.